A phase 3 trial of cabozantinib, zanzalintinib, atezolizumab, nivolumab and other drugs in colorectal cancer, run by Exelixis, now recruiting.
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study is a phase 3, interventional study registered as NCT07620574 by Exelixis, with a registry enrolment figure of 5000 participants, started 2026-07-30 and due to reach its primary completion in 2030-05-31. Interventions recorded: Cabozantinib; Zanzalintinib; Atezolizumab; Nivolumab; Abiraterone; Prednisone; Enzalutamide. Conditions listed: Cancer; Renal Cell Carcinoma (RCC); Pancreatic Neuroendocrine Tumors (pNET); Extra-Pancreatic NET (epNET); Hepatocellular Carcinoma (HCC); Differentiated Thyroid Cancer (DTC); Non-Clear Cell Renal Cell Carcinoma (nccRCC); Colorectal Cancer; Prostate Cancer. Primary outcome: Number of Participants With Treatment Emergent Adverse Events (TEAEs). Sites: United States. No results are recorded here; the registry entry is the source.
Shares Zanzalintinib, Exelixis, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Exelixis, Cabozantinib, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Bristol Myers Squibb, Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Zanzalintinib, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Atezolizumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.